← Back to Search

SAFETY-Acute intervention for Suicide Prevention

N/A
Waitlist Available
Led By David Goldston, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2-month follow-up assessment
Awards & highlights

Study Summary

This trial is designed to develop and refine an intervention for suicidal youth, and to test its feasibility. Data will be collected from 20 youth at one juvenile detention facility, who will be assessed at 3 different points in time. The trial will examine the effect of the intervention on suicidal thoughts and behavior, self-injury, and mechanisms of change.

Eligible Conditions
  • Suicide Prevention

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 month follow-up assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 month follow-up assessment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Linkage to Mental Health Services After Release
Non-suicidal Self Injury
Suicide Attempts
Secondary outcome measures
Acceptance
Emergency Mental Health Services (ED visits and hospitalizations)
Hope and Reasons for Living
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: SAFETY-A Implementation SitesExperimental Treatment1 Intervention
New Brief Trauma-Informed Intervention (based on SAFETY-A) in addition to Enhanced Usual Care in Juvenile Detention Sites

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,358 Previous Clinical Trials
3,419,849 Total Patients Enrolled
3 Trials studying Suicide Prevention
2,074 Patients Enrolled for Suicide Prevention
National Institute of Mental Health (NIMH)NIH
2,783 Previous Clinical Trials
2,688,907 Total Patients Enrolled
26 Trials studying Suicide Prevention
124,675 Patients Enrolled for Suicide Prevention
David Goldston, PhDPrincipal InvestigatorDuke University
1 Previous Clinical Trials
1,516 Total Patients Enrolled
1 Trials studying Suicide Prevention
1,516 Patients Enrolled for Suicide Prevention

Media Library

Suicide Prevention Clinical Trial 2023: SAFETY-Acute intervention Highlights & Side Effects. Trial Name: NCT05225103 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age restriction for this study inclusive of those over 35?

"The eligibility criteria for this study stipulates that participants must be between 13 and 17 years old."

Answered by AI

Who else is applying?

What site did they apply to?
Duke University
What portion of applicants met pre-screening criteria?
Did not meet criteria
~73 spots leftby Oct 2024